From mechanisms to anti-fibrotic drugs in hepatic stellate cell research: a global bibliometric analysis with patent and clinical perspectives (2000–2025)
Integrating bibliometrics with patent and clinical landscapes, this study delineates an evolution from mechanism discovery to precision intervention in HSC - focused LF research. Future priorities include improving target/tissue specificity and advancing multimodal, patient stratified strategies to enhance translational efficiency.
Authors
- Yuan Zhao (ORCID: https://orcid.org/0000-0002-7573-4936)
- Na Guan
- Xiao Wen Mao (ORCID: https://orcid.org/0000-0002-4508-8689)
- Peng Chen (ORCID: https://orcid.org/0000-0001-7936-7873)
- Yi Liu (ORCID: https://orcid.org/0009-0000-6283-8229)
- Bin Li (ORCID: https://orcid.org/0000-0002-8607-8874)
- Siwei Zhang (ORCID: https://orcid.org/0000-0002-1646-063X)
- Palidan Wubur
Institutions
- Xinjiang Medical University (CN)
- Baoji University of Arts and Sciences (CN)
- Xi'an Medical University (CN)
- Baoji City Central Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-12-10
- DOI
- https://doi.org/10.3389/fphar.2025.1734449
- Primary Topic
- Liver physiology and pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Xi'an Medical University
- U.S. National Library of Medicine